Newly published data in Cancer Immunology, Immunotherapy support the potential of Secarna Pharmaceuticals’ LNA-modified ASOs to effectively block important immunosuppressive pathway

CENTOGENE AG: CENTOGENE startet Pilotprojekt zur Diagnose von unentdeckten Covid-19-Fällen

Secarna Pharmaceuticals announces the acquisition of LNAplusTM based antisense drug candidates by Lipigon Pharmaceuticals

Heidelberg Pharma AG: Heidelberg Pharma Announces Financial Figures for Fiscal Year 2019 and Provides Business Update

Abivax 2019 Financial Results and Operations Update

dievini comments on press releases about CureVac

Adocia Announces Full Year 2019 Financial Results

Abivax 2020 Financial Communication Calendar

Newron updates on STARS study FDA interaction

International Women’s Day 8 March: LKF conducts research on women’s health with women leading the way